RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Rezolute, Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 24, 2026
$3.70+0.12 (+3.35%)
Close on Oct 19, 2026
- Market cap
- $386.60M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Oct 13, 2020 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Oct 7, 2020 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| May 1, 2014 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |